Back to search
Cognitive Impairment Associated With Schizophrenia (CIAS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cognitive Impairment Associated With Schizophrenia (CIAS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cognitive Impairment Associated With Schizophrenia (CIAS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study aims to evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS).…
This is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of…
The goal of this clinical trial is to evaluate if the investigational drug, RL-007, can improve the cognitive performance of subjects with schizophrenia. The ma…
Study to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.